Ep. 216 - Anti-China Biotech Policy: Biosecure & Beyond

from BioCentury This Week · host BioCentury

Anti-China biotech bills are raising alarms at U.S. biotechs, with CEOs worried they could lose access to CDMOs WuXi AppTec and WuXi Biologics, and that legislation could imperil collaboration with Chinese companies more broadly. BIO has warned Congress the bills “would immediately and negatively” affect the U.S. biotech ecosystem. On this special edition of the BioCentury This Week podcast BioCentury Washington Editor Steve Usdin and colleagues discuss the pending legislation.Reach us by sending a text

Episode metadata supplied by the publisher feed · Published Feb 16, 2024

Embed this episode

Attribution link and audio player

NOW PLAYING

Ep. 216 - Anti-China Biotech Policy: Biosecure & Beyond

0:00 26:38

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of BioCentury This Week?

This episode is 26 minutes long.

When was this BioCentury This Week episode published?

This episode was published on February 16, 2024.

Can I download this BioCentury This Week episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!